Clinical Trials Logo

Filter by:
NCT ID: NCT00302016 No longer available - Clinical trials for Chronic Myeloid Leukemia

Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia

Start date: January 2006
Phase: Phase 3
Study type: Expanded Access

This study will further evaluate if AMN107 is safe in adults with chronic myeloid leukemia who are resistant or intolerant to imatinib and to provide patients access to this new drug until the drug becomes commercially available.

NCT ID: NCT00300781 Completed - Neoplasms Clinical Trials

Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer

Start date: August 4, 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to learn whether neratinib is safe and effective in treating women with advanced human epidermal growth factor receptor 2 (HER2) positive breast cancer.

NCT ID: NCT00300339 Completed - Clinical trials for Intermittent Claudication

Mixed Antagonist of Serotonin for Claudication Optimal Therapy

MASCOT
Start date: February 2006
Phase: Phase 2
Study type: Interventional

To investigate in patients suffering from intermittent claudication due to Fontaine stage II PAD whether a 24-week treatment by SL650472 OD on top of clopidogrel may result in an improvement of walking capacity, by comparing three doses of SL650472 to placebo, and to calibrate such effect versus cilostazol

NCT ID: NCT00298051 Completed - Clinical trials for Iron-deficiency Anemia

Umbilical Cord Clamping and Infant Iron Status

Start date: October 2003
Phase: N/A
Study type: Interventional

The aim of the study was to determine whether delayed umbilical cord clamping, as compared to early umbilical cord clamping, improves infant iron status at 6 months of age.

NCT ID: NCT00296855 Completed - Clinical trials for Peripheral Vascular Diseases

Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA With a Conventional Extracellular Contrast Agent With X-ray Angiography in Patients With Peripheral Artery Disease

Start date: February 2006
Phase: Phase 3
Study type: Interventional

The particular aim of this study is the comparison of the diagnostic results of MRA images upon application of Vasovist (gadofosveset), a contrast agent not yet available on the market, with the MRA images upon application of a conventional extracellular contrast agent. A catheter angiography, which will be performed as a routine diagnostic procedure for vascular diseases, will serve as an evaluation standard.

NCT ID: NCT00296400 Completed - Hyperlipidemia Clinical Trials

Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease

PLANET II
Start date: February 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effects of Crestor (rosuvastatin) and (Lipitor) atorvastatin on urinary protein excretion over 1 year in non-diabetes with moderate proteinuria and hypercholesterolaemia.

NCT ID: NCT00296374 Completed - Diabetes Mellitus Clinical Trials

Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease

PLANET 1
Start date: February 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effects of Crestor (rosuvastatin) and (Lipitor) atorvastatin on urinary protein excretion over 1 year in patients with Type 1 or 2 diabetes with moderate proteinuria and hypercholesterolaemia.

NCT ID: NCT00295815 Completed - Glioblastoma Clinical Trials

Enzastaurin Versus Lomustine in Glioblastoma

Start date: January 2006
Phase: Phase 3
Study type: Interventional

This protocol will test the activity of Enzastaurin vs. Lomustine in the treatment of recurrent brain cancer (specifically intracranial glioblastoma multiforme).

NCT ID: NCT00295750 Completed - Prostate Cancer Clinical Trials

The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer

Start date: February 2006
Phase: Phase 3
Study type: Interventional

The study was a three-arm, active-control, multi-centre, parallel group study.

NCT ID: NCT00295633 Completed - Clinical trials for Diabetes Mellitus, Type 2

A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone

Start date: March 2006
Phase: Phase 3
Study type: Interventional

The purpose of this clinical research study is to learn whether Saxagliptin added to thiazolidinedione (TZD) therapy is more effective than TZD alone as a treatment for Type 2 diabetic subjects who are not sufficiently controlled with TZD alone